StockNews.com Initiates Coverage on Enzo Biochem (NYSE:ENZ)

Analysts at StockNews.com initiated coverage on shares of Enzo Biochem (NYSE:ENZ) in a report issued on Thursday. The firm set a “hold” rating on the medical research company’s stock.

Enzo Biochem Trading Up 2.2 %

ENZ stock opened at $0.74 on Thursday. The firm has a 50 day moving average price of $0.97 and a 200-day moving average price of $1.07. Enzo Biochem has a 52-week low of $0.68 and a 52-week high of $1.44.

Enzo Biochem (NYSE:ENZ) last released its quarterly earnings data on Monday, December 16th. The medical research company reported ($0.05) earnings per share (EPS) for the quarter. Enzo Biochem had a negative net margin of 81.73% and a negative return on equity of 11.84%.

Hedge Funds Weigh In On Enzo Biochem

A number of institutional investors and hedge funds have recently made changes to their positions in the business. BBR Partners LLC bought a new position in shares of Enzo Biochem during the 3rd quarter valued at approximately $112,000. Renaissance Technologies LLC boosted its holdings in shares of Enzo Biochem by 2.6% during the 2nd quarter. Renaissance Technologies LLC now owns 2,499,546 shares of the medical research company’s stock valued at $2,725,000 after purchasing an additional 64,417 shares during the last quarter. XTX Topco Ltd grew its position in shares of Enzo Biochem by 94.5% during the second quarter. XTX Topco Ltd now owns 28,262 shares of the medical research company’s stock valued at $31,000 after purchasing an additional 13,735 shares in the last quarter. Finally, Geode Capital Management LLC increased its holdings in shares of Enzo Biochem by 3.3% in the third quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock worth $413,000 after purchasing an additional 11,742 shares during the last quarter. Hedge funds and other institutional investors own 36.90% of the company’s stock.

Enzo Biochem Company Profile

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.